By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...

Research teams across Canada are now building mRNA to expand the potential of RNA vaccines beyond infectious diseases.

The administration of influenza and COVID-19 vaccines leads to small changes in the length of the menstrual cycle, ...

The Trump administration’s unprecedented $500 million grant for a broadly protective flu shot has confounded vaccine and ...

In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, ...

There's been progress, but the future of federal funding for health care systems is in limbo, casting this progress into an uncertain future.

Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future ...

HHS: Kennedy says he is not opposed to vaccination, but described them as a personal choice in the midst of a large U.S.

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra Calabrese, DO, said during her presentation at Updates in Primary ...